Detalles de la búsqueda
1.
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
BMC Infect Dis;
22(1): 245, 2022 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279084
2.
Restoration of Bacterial Microbiome Composition and Diversity Among Treatment Responders in a Phase 2 Trial of RBX2660: An Investigational Microbiome Restoration Therapeutic.
Open Forum Infect Dis;
6(4): ofz095, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31024971
Resultados
1 -
2
de 2
1
Próxima >
>>